The Food and Drug Administration (FDA) this month approved tebipenem pivoxil for adults with complicated urinary tract infections (cUTIs), including pyelonephritis, in patients who have limited or no alternative oral treatment options. Marketed as Utebzi, it is one of the more significant antibiotic approvals in recent years because it is the first oral carbapenem antibiotic available in the United States, according to manufacturer GSK. Until now, carbapenems (eg, ertapenem, meropenem, and imipenem) have generally required …
Read More
